Adjuvant Holdings Co.,Ltd. (TYO:4929)
745.00
-1.00 (-0.13%)
Apr 28, 2026, 3:30 PM JST
Adjuvant Holdings Revenue
In the fiscal year ending March 20, 2026, Adjuvant Holdings had annual revenue of 3.81B JPY, down -6.95%. Adjuvant Holdings had revenue of 692.00M in the quarter ending March 20, 2026, a decrease of -18.40%.
Revenue
3.81B
Revenue Growth
-6.95%
P/S Ratio
1.56
Revenue / Employee
30.75M
Employees
124
Market Cap
5.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 20, 2026 | 3.81B | -285.00M | -6.95% |
| Mar 20, 2025 | 4.10B | -340.00M | -7.66% |
| Mar 20, 2024 | 4.44B | 61.00M | 1.39% |
| Mar 20, 2023 | 4.38B | -50.00M | -1.13% |
| Mar 20, 2022 | 4.43B | -458.00M | -9.38% |
| Mar 20, 2021 | Pro | Pro | Pro |
| Mar 20, 2020 | Pro | Pro | Pro |
| Mar 20, 2019 | Pro | Pro | Pro |
| Mar 20, 2018 | Pro | Pro | Pro |
| Mar 20, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Almado | 10.18B |
| HABA Laboratories,Inc. | 12.17B |
| Premier Anti-Aging | 14.97B |
| C'BON COSMETICS | 9.22B |
| Sagami Rubber Industries | 5.79B |
| AXXZIA | 13.97B |
| Axas Holdings | 12.48B |
| Liberta | 10.03B |